During the pandemic, interest in special purpose acquisition companies (SPAC) soared, as private cannabis-related businesses looked to these blank-check companies for quicker, easier access to public markets and the funding that comes with it.
But two years later, the sparkle seems to be dimming.
We’ve talked a lot about the different channels for receiving external funding for your cannabis operations – and how convoluted some of those deals can be.
California cannabis operators cheered when Gov. Gavin Newsom pledged to overhaul the state’s tax structure to shore up the troubled industry.
While the proposal is short on details, reducing state tax burdens could be an immediate boost to a company’s bottom line.
MJBiz is gearing up to produce its 10th annual MJBizFactbook, and we need your help.
If you’re a marijuana business operator or own a company that serves or invests in the cannabis industry, help MJBiz by participating in our business survey.
Considering starting a cannabis laboratory?
Think it’s a gold mine for the taking?
Think again!
Laboratory testing is not for the faint of heart and can be downright cutthroat under some circumstances.
Wouldn’t it be great if words that we’re tired of could just stop being part of our reality?
We’ve lived in “unprecedented” and “uncertain” times for nearly two years, thanks to the COVID-19 pandemic. It’s disrupted our daily lives and our business operations.
While capital has become more accessible for many marijuana firms, sometimes the decision to extend funds is more about protecting a position than actually supporting a cannabis operator’s trajectory.
Multistate operator Curaleaf Holdings (CSE: CURA; OTCQB: CURLF) on Dec. 28 announced the acquisition of Bloom Dispensaries, a private, integrated Arizona marijuana operator, in a deal valued at $211 million.
While wholesale cannabis prices have been going up – sometimes as much as 30%, according to a recent MJBizDaily story – retail prices for the consumer haven’t been keeping pace.
A new study of cannabis vape products from California collected during the vaping crisis of 2019 and 2020 underscored what many in the industry already know: The complexities of cannabis necessitate thorough analysis before product formulation manufacturing.
Curaleaf deal sets bar higher for marijuana debt financing, and investor interest in environmental, social and governance (ESG) policies.
Congress stripped the SAFE Banking Act from a defense spending bill this week, decreasing the possibility of meaningful federal marijuana reform before the end of the year.
